Skip to content

Overactive Bladder Education

Overactive Bladder Education

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02505607
Enrollment
22
Registered
2015-07-22
Start date
2015-07-31
Completion date
2015-12-31
Last updated
2015-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Bladder, Overactive, Urinary Incontinence, Urge

Brief summary

Overactive bladder (OAB) is a common, chronic condition, characterized by urinary urgency, with or without urge incontinence, usually with frequency and nocturia. Treatment adherence is a major barrier to management of OAB and drug continuation is poor. Many factors may play a role in non-adherence to medication management of OAB including drug cost, side effects, and a lack of understanding of the disease and treatment process.Studies show that recall of disease information and treatment is often suboptimal. Literature shows that providing written materials is an efficacious way to aid in recall. Based on known poor adherence to OAB medication treatment and the clear role patient education methods have on patient information recall, the investigators believe that improvement of participant education through use of a OAB care plan will improve participant understanding and treatment adherence. Through this randomized trial, the investigators plan to evaluate whether implementation of a OAB Care Plan improves understanding of disease and treatment options, treatment success, and satisfaction. This is a prospective, randomized, controlled study of OAB counseling in new patients presenting to the Urogynecology offices of Hartford Hospital. All new patients with a diagnosis of OAB will be offered participation. All consenting participants will be randomized 1:1 to one of two groups: 1) Standard Care group or 2) Care Plan group. In the Standard Care group, participants will be counseled as the physician routinely counsels patients about OAB, in the Care Plan group, participants will be counseled a printed Overactive Bladder Plan of Care information sheet. At the end of the visit, the participant will complete a Baseline Survey. The Baseline Survey includes basic demographic information, a physician satisfaction survey, and a OAB knowledge survey. The participant will return for follow up as directed by the physician. At the follow up visit, participants in both groups will complete a Followup Survey. The Followup Survey will be completed before the participant sees the physician. The Followup Survey assesses OAB knowledge. Eight months after the baseline visit, each participant's chart will be reviewed for final data collection. If a participant progresses to a treatment method where she is satisfied and would like to remain, this will be documented.

Interventions

OTHEROveractive Bladder Care Plan counseling

Use of a printed Overactive Bladder Plan of Care information sheet.

Sponsors

Hartford Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of overactive bladder * able and willing to participate and consent * age \>17 years, \<90 years * female sex

Exclusion criteria

* male sex * patients who do not have a diagnosis of overactive bladder * age \<18 years, \>89 years * unable or unwilling to participate * patients who are already being treated for overactive bladder * patients who are planning surgical intervention for pelvic organ prolapse prior to treatment of overactive bladder * patients who are planning surgical intervention for stress urinary incontinence prior to treatment of overactive bladder * pregnancy

Design outcomes

Primary

MeasureTime frame
Understanding of Overactive Bladder questionnaireChange from baseline knowledge at follow up visit (on average 8 weeks)

Secondary

MeasureTime frame
Subject satisfaction questionnaireBaseline visit (time 0)
Treatment success chart review8 months after baseline visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026